WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca today added to its biologics manufacturing capability in the
US with the purchase of a high-tech biologics bulk manufacturing
facility from Amgen Inc. About Zovirax (Acyclovir) with free prescription Over time, the LakeCentre facility, located in
Boulder, Colorado will increase manufacturing and production capacity to
support the company’s extensive portfolio of biologics medicines.
AstraZeneca plans to start staffing the facility immediately to support
refurbishment and infrastructure improvements. Azelex (Azelaic Acid) without Rx Once complete, the site
is expected to be operational and licensed for commercial production by
late 2017, providing for additional capacity within the company’s
biologics operations.
In the longer- term, this site could create up to 400 highly skilled
jobs, subject to relevant approvals by the local authorities. Adalat (Nifedipine) without prescription The
facility will eventually double the biologics manufacturing capacity in
the US to meet the needs of the maturing AstraZeneca pipeline. Femara with free prescription Currently
biologics make up 50 percent of the company’s pipeline with more than
120 ongoing programmes, including over 30 in clinical development.
Pam Cheng, Executive Vice-President, Operations and Information
Technology at AstraZeneca, said: “The addition of the Boulder facility
will support the progression of biotech drug candidates across our main
therapeutic areas as we continue to bring innovative new treatments to
patients. About Man XXX () with no prescription This site will play an important role in our future commercial
production and give AstraZeneca and MedImmune, our global biologics
research and development arm, the flexibility and capacity to meet the
needs of our rapidly growing biologics portfolio.”
The new facility in Boulder adds to the expansion of AstraZeneca’s
biologics manufacturing capabilities, following the planned biologics
manufacturing investment in Sweden, announced
in May, and the expansion in Frederick, Maryland, announced
in November 2014.
The financial details were not disclosed. Buy Cayenne online This investment does not
impact AstraZeneca’s financial guidance for 2015.
– ENDS –
NOTES TO EDITORS
About AstraZeneca
AstraZeneca is a global, innovation-driven biopharmaceutical business
that focuses on the discovery, development and commercialisation of
prescription medicines, primarily for the treatment of cardiovascular,
metabolic, respiratory, inflammation, autoimmune, oncology, infection
and neuroscience diseases. http://medical-reviews.blogspot.com AstraZeneca operates in over 100 countries
and its innovative medicines are used by millions of patients worldwide.
For more information please visit: .astrazeneca.com
No comments:
Post a Comment